pembrolizumab,gemcitabine,docetaxel,vibostolimab,favezelimab
merck
['docetaxel', 'mibc', 'pembro', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'gemcitabine', 'bladder']
innovative and pragmatic methods to study bcg unresponsive nonmuscle-invasive #bladdercancer. presented by . #gu23 written coverage by on urotoday &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology